Determination of torasemide in human plasma and its bioequivalence study by high-performance liquid

来源 :Journal of Pharmaceutical Analysis | 被引量 : 0次 | 上传用户:luoxingrobin
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
A sensitive and selective method using high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry(HPLC–ESI–MS) to determine the concentration of torasemide in human plasma samples was developed and validated. Tolbutamide was chosen as the internal standard(IS). The chromatography was performed on a Gl Sciences Inertsil ODS-3 column(100 mm*2.1 mm i.d., 5.0μm) within 5 min, using methanol with 10 mM ammonium formate(60:40, v/v) as mobile phase at a fl ow rate of 0.2 mL/min. The targeted compound was detected in negative ionization at m/z 347.00 for torasemide and 269.00 for IS. The linearity range of this method was found to be within the concentration range of 1–2500 ng/mL(r=0.9984) for torasemide in human plasma. The accuracy of this measurement was between 94.05% and 103.86%. The extracted recovery ef fi ciency was from 84.20% to 86.47% at three concentration levels. This method was also successfully applied in pharmacokinetics and bioequivalence studies in Chinese volunteers. A sensitive and selective method using high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry (HPLC-ESI-MS) to determine the concentration of to plasmamide was developed and validated. Tolbutamide was chosen as the internal standard (IS) . The Chromatography was performed on a Gl Sciences Inertsil ODS-3 column (100 mm * 2.1 mm id, 5.0 μm) within 5 min using methanol with 10 mM ammonium formate (60:40, v / v) as mobile phase at a fl ow rate of 0.2 mL / min. The targeted compound was detected in negative ionization at m / z 347.00 for torasemide and 269.00 for IS. The linearity range of this method was found to be within the concentration range of 1-2500 ng / mL (r = 0.9984) for torasemide in human plasma. The accuracy of this measurement was between 94.05% and 103.86%. The extracted recovery ef fi ciency was from 84.20% to 86.47% at three concentration levels. This method was also successfully applied in pharmacokinetics and bioe quivalence studies in Chinese volunteers.
其他文献
1例39岁男性患者因高血压病服用苯磺酸氨氯地平5 mg/d,用药1周后因血压控制欠佳、心率偏快加服琥珀酸美托洛尔缓释片23.75 mg/d。加药1 d后出现尿频(10次/d),且尿频逐渐加重,达10~15次/d。1周后患者自行停服苯磺酸氨氯地平,尿频未见缓解;2周后自行停服琥珀酸美托洛尔,1 d后尿频缓解(4~6次/d)。因血压不稳定,遵医嘱再次口服琥珀酸美托洛尔后尿频复现,停药后再次缓解。
目的评估Ex-PRESS青光眼引流器植入联合可调整缝线治疗难治性青光眼的效果。方法回顾性分析2013年2月至2018年4月难治性青光眼39例(39眼)的临床资料。所有患者行Ex-PRESS青光眼引流器植入联合应用可调整缝线治疗。结果术后6个月,矫正视力提高者12眼,无明显改变者24眼,视力下降3眼。术前平均眼压(47.49±10.16)mmHg(1 mmHg=0.133 kPa)。术后1天、1周、
目的探讨后部眼球筋膜下注射曲安奈德联合激光光凝治疗视网膜中央静脉阻塞(CRVO)所致黄斑水肿的临床效果。方法回顾性分析2016年6月至2018年5月收治CRVO 60例(60眼)的临床资料。所有患者于后部眼球筋膜下注射曲安奈德后1周,行视网膜激光光凝。结果治疗后6个月,57例(95.00%)视力提高,45例(75.00%)黄斑水肿明显减轻,无1例发生增生性玻璃体视网膜病变或新生血管性青光眼。结论后
Objective:To investigate the cytotoxic activity of endophytic fungi isolated from mangrove fungi.Methods:In the present study the DNA was isolated and the ITS r
期刊
通过对《中医病证诊断疗效标准》《周围血管疾病中西医诊疗学》《中药新药临床研究指导原则》《周围血管病中医研究最新全书》及统编教材《中医外科学》《中西医结合外科学》
Objective: To detect leptospiral antibodies by microscopic agglutination test (MAT) in north-east of Iran. Methods: This study was conducted to evaluate prevale
目的 研究探讨宫颈癌前病变应用宫颈环型电切术(LEEP)治疗的临床效果.方法 随机选取2016年1月至2018年1月于我院接受治疗的宫颈癌前病变(CIN)患者200例,其根据患者宫颈癌前病
胆管癌是指肝外胆管癌和胆囊癌,也是恶性阻塞性黄疸(obstructive jaundice,OJ)的主要病因,多数患者出现临床症状时已属进展期,伴远隔转移,预后差.目前,影像学检查仍是主要诊
目的观察硅胶带植入术治疗青光眼引流阀植入术后滤过泡机化包裹的新方法。方法回顾性分析本院2017年4月至2019年5月经结膜滤过泡囊壁切开行硅胶带植入术治疗Ahmed青光眼阀机化包裹导致的高眼压10例(10眼)的临床资料。术后随访2~23个月,平均(10.10±8.21)个月。结果眼压升高者术后5天1例,术后3个月2例,术后6个月2例,余5例在随访期间内眼压保持在6.5~21.0 mmHg之间(1